Special explanation on the summary table of non-operating fund occupation and other related fund transactions of Haili Biotechnology (Xihuishenzi [2026] No. 2429)
Special explanation on the summary table of non-operating fund occupation and other related fund transactions of Shanghai Haili Biotechnology Co., Ltd.
hope Huishen Zi (2026) No. 2429
Directory
1. Special instructions................................................................................ (1-2)
2. Appendix................................................................................................(3)
3. Copy of certificate
(1) Certified public accountant qualification certificate
(2) Accounting firm business license
(3) Accounting firm practice certificate
Xigema Cpas (Special General Partnership)
hope Huishen Zi (2026) No. 2429
About Shanghai Haili Biotechnology Co., Ltd.
Occupation of non-operating funds and other related funds
Special instructions for the transaction summary table
All shareholders of Shanghai Haili Biotechnology Co., Ltd.:
We accepted the entrustment and audited the 2025 financial statements of Shanghai Haili Biotechnology Co., Ltd. (hereinafter referred to as "your company") in accordance with the Chinese Certified Public Accountants Auditing Standards. Including the consolidated and parent company's balance sheet on December 31, 2025, the consolidated and parent company's income statement, the consolidated and parent company's cash flow statement, the consolidated and parent company's statement of changes in shareholders' equity, and notes to the financial statements for 2025. An unqualified audit report No. Xihuishenzi (2026) 0390 was issued on April 28, 2026.
In accordance with the requirements of the "Regulatory Guidelines for Listed Companies No. 8 - Regulatory Requirements for Capital Transactions and External Guarantees of Listed Companies" issued by the China Securities Regulatory Commission in conjunction with the Ministry of Public Security, the State-owned Assets Supervision and Administration Commission, and the China Banking and Insurance Regulatory Commission and the "Shanghai Stock Exchange Self-Regulatory Supervision Guidelines for Listed Companies No. 2 - Business Handling", your company has prepared the attached summary table of non-operating fund occupation and other related fund transactions of Shanghai Haili Biotechnology Co., Ltd. in 2025 (hereinafter referred to as the "Summary Table").
It is the responsibility of your company's management to truthfully prepare and disclose the summary statement to the outside world and ensure that it is true, legal and complete. We have checked the information contained in the summary table with the accounting information reviewed by the firm when we audited your company's 2025 financial statements and the relevant content of the audited financial statements, and no inconsistencies were found in all material aspects. In addition to the audit procedures related to related party transactions performed in the audit of your company's 2025 financial statements, we have not performed additional audit procedures on the information contained in the summary table. In order to better understand your company's non-operating fund occupation and other related fund transactions, the attached summary table should be read together with the audited 2025 financial statements.
This special statement is only for your company to disclose the occupation of non-operating funds and other related fund transactions.